Spex Eyebrow documentation

Spex’s eyebrow experiment and documentation with Lumigan (bimatoprost ophthalmic 0.03% solution ).

I’ve never had the strongest eyebrows and after speaking to many people and in particular Dr Feriduni regarding eyebrows I’ve decided to do an experiment which I intend to document here to see the benefits of applying Lumigan for 8-12 months to see if and to what degree it can help bulk up and assist my weak eyebrows. Patients I have spoken too who have applied this to their eyebrows have spoken of solid improvements.

I have a number of baby/miniaturized hairs in the eyebrow that hopefully with the use of Lumigan I can strengthen and salvage – Time will tell.

Bimatoprost is a prostaglandin analogue sold in the US, Canada and Europe by the pharmaceutical company Allergan. It was first marketed under the trade name Lumigan (bimatoprost ophthalmic solution 0.01% or 0.03%) to reduce intraocular pressure in patients with glaucoma or ocular hypertension. In the UK you require a private prescription from your GP for it.

Researchers noticed the drug had the side effect of stimulating eyelash growth and darkening of the eyelashes in patients with glaucoma.

Allergan re-applied for US Food and Drug Administraton (FDA) approval for bimatoprost for the cosmetic purpose of eyelash growth under the new name Latisse.

In December 2008, bimatoprost ophthalmic solution 0.03% was approved by the FDA as a treatment for eyelash hypotrichosis (inadequate or not enough eyelashes).

My Left eyebrow today on 11th March 2015